国际肝病：在今年的会议上有很多关于索拉菲尼的研究报道。

Hepatology Digest: There is obviously a lot of talk about sorafenib at this year's meeting.

youdao

在近来的方案中，索拉·菲尼将成为这些实验中的控制臂。

In the latter scenario, sorafenib should also constitute the control arm of these trials.

youdao

在近来的方案中，索拉·菲尼将成为这些实验中的控制臂。

In the latter scenario, sorafenib should also constitute the control arm of these trials.

youdao